781 A randomized phase II trial of gemcitabine and either day 1 or day 8 carboplatin for advanced non-small cell lung cancer (NSCLC)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(03)90806-8 ◽

2003 ◽

Vol 1 (5) ◽

pp. S235

Author(s):

J. Iglesias ◽

C. Crombie ◽

W.I. Burns ◽

C. Karapetis ◽

R.M. Lowenthal ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Randomized Phase Ii

Download Full-text

Randomized Phase II Trial of Sequential Chemotherapy in Advanced Non-Small Cell Lung Cancer (SWOG 9806)

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-04-0002 ◽

2004 ◽

Vol 10 (15) ◽

pp. 5022-5026 ◽

Author(s):

Martin J. Edelman ◽

Joseph I. Clark ◽

Kari Chansky ◽

Kathy Albain ◽

Nirmala Bhoopalam ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Sequential Chemotherapy ◽

Randomized Phase Ii

Download Full-text

A randomized phase II trial of ERCC1 and RRM1 mRNA expression-based chemotherapy versus docetaxel/carboplatin in advanced non-small cell lung cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-016-2968-z ◽

2016 ◽

Vol 77 (3) ◽

pp. 539-548 ◽

Author(s):

Su Jin Heo ◽

Inkyung Jung ◽

Choong-kun Lee ◽

Jee Hung Kim ◽

Sun Min Lim ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Mrna Expression ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Randomized Phase Ii

Download Full-text

A Randomized Phase II Trial Using Two Different Treatment Schedules of Gemcitabine and Carboplatin in Patients with Advanced Non???Small-Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1097/01243894-200601000-00006 ◽

2006 ◽

Vol 1 (1) ◽

pp. 19-24 ◽

Author(s):

Gregory A. Masters ◽

Athanassios E. Argiris ◽

Elizabeth A. Hahn ◽

J Thaddeus Beck ◽

P Gregory Rausch ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Randomized Phase Ii

Download Full-text

Pioglitazone and clarithromycin combined with metronomic low-dose chemotherapy versus nivolumab in patients with advanced non-small cell lung cancer treated in 2nd-line and beyond: Outcomes from a randomized phase II trial (ModuLung)

Annals of Oncology ◽

10.1093/annonc/mdz260.092 ◽

2019 ◽

Vol 30 ◽

pp. v646-v647 ◽

Author(s):

D. Heudobler ◽

C. Schulz ◽

J.R. Fischer ◽

P. Staib ◽

T. Wehler ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Low Dose ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Randomized Phase Ii ◽

Low Dose Chemotherapy

Download Full-text

An Exploratory Randomized Phase II Trial Comparing CDDP Plus S-1 With Bevacizumab and CDDP Plus Pemetrexed With Bevacizumab Against Patients With Advanced Non-squamous Non-small Cell Lung Cancer

Anticancer Research ◽

10.21873/anticanres.13368 ◽

2019 ◽

Vol 39 (5) ◽

pp. 2483-2491 ◽

Author(s):

KYOICHI KAIRA ◽

HISAO IMAI ◽

RYOUSUKE SOUMA ◽

REIKO SAKURAI ◽

YOSUKE MIURA ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Randomized Phase Ii

Download Full-text

Randomized Phase II Trial of Metformin in Combination with Chemoradiotherapy (CRT) in Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC); the OCOG-ALMERA trial (NCT02115464)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2020.07.2284 ◽

2020 ◽

Vol 108 (3) ◽

pp. S104

Author(s):

T. Tsakiridis ◽

G. Pond ◽

J. Wright ◽

P. Ellis ◽

B.S. Abdulkarim ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

Small Cell Lung ◽

Randomized Phase Ii

Download Full-text

Randomized phase II trial comparing two chemotherapy combinations for non-small cell lung cancer: Mitomycin, ifosfamide, and cisplatin versus vindesine, ifosfamide, and cisplatin

Lung Cancer ◽

10.1016/0169-5002(94)90848-6 ◽

1994 ◽

Vol 10 (5-6) ◽

pp. 417

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Randomized Phase Ii

Download Full-text

3079 Randomized phase II trial of amrubicin plus irinotecan versus cisplatin plus irinotecan in chemo-naïve patients with extensivedisease small-cell lung cancer: Results of the Japan Multinational Trial Organization (JMTO) LC 08-01

European Journal of Cancer ◽

10.1016/s0959-8049(16)31720-8 ◽

2015 ◽

Vol 51 ◽

pp. S623-S624

Author(s):

A. Tamiya ◽

H. Yoshioka ◽

T. Nishimura ◽

Y. Iwamoto ◽

Y.H. Kim ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Multinational Trial ◽

Randomized Phase Ii

Download Full-text

Randomized Phase II Trial of High-Dose 4’-Epi-Doxorubicin + Cyclophosphamide versus High-Dose 4’-Epi-Doxorubicin + Cisplatin in Previously Untreated Patients with Extensive Small Cell Lung Cancer

Oncology ◽

10.1159/000227066 ◽

1992 ◽

Vol 49 (5) ◽

pp. 327-332 ◽

Author(s):

E. Kánitz ◽

K. Kolaric ◽

J. Jassem ◽

Z. Mechl ◽

M. Pawlicki ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

High Dose ◽

Small Cell Lung ◽

Randomized Phase Ii

Download Full-text

Randomized phase II trial comparing every-3-week carboplatin/paclitaxel (C/P) versus every-3-week C with weekly P in advanced non-small cell lung cancer (NSCLC)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.7073 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7073-7073

Author(s):

H. B. Niell ◽

M. A. Socinski ◽

K. Bakri ◽

J. Wall ◽

M. Baggstrom ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Randomized Phase Ii

Download Full-text